Correspondence
Source: The International Journal of Tuberculosis and Lung Disease, Volume 8, Number 9, September 2004 , pp. 1157-1158(2)
Publisher: International Union Against Tuberculosis and Lung Disease
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Is second-line anti-tuberculosis drug susceptibility testing reliable? S. J. Kim and M. A. Espinal, Stop TB Department, Tuberculosis Strategy and Operations, World Health Organization, Geneva, Switzerland; C. Abe, Research Institute of Tuberculosis, Japan Anti-TB Association, Tokyo, Japan; G. H. Bai, Korean Institute of Tuberculosis, Korean National TB Association, Seoul, Korea; F. Boulahbal, Laboratoire de la Tuberculose, Institut Pasteur d'Algérie-Alger, Alger, Algeria; L. Fattorini, Instituto Superiore de Sanita Laboratory of Bacteriology & Medical Mycology, Rome, Italy; C. Gilpin, Queensland Mycobacterium Reference Laboratory, The Prince Charles Hospital, Queensland Health, Brisbane, Australia; S. Hoffner, Swedish Institute for Infectious Disease Control, Solna, Sweden; K. M. Kam, Tuberculosis Reference Laboratory, Public Health Laboratory Complex, Department of Health, Hong Kong, China; N. Martin-Casabona, Servei de Microbiologia Hospita, Universitarie Vall d'Hebron, Barcelona, Spain; L. Rigouts, Department of Micobiology, Mycobacteriology Unit Institute of Tropical Medicine, Antwerpen, Belgium; and V. Vincent, Centre National de Référence des Mycobactéries Institut Pasteur, Paris, FranceDocument Type: Letter paper
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help